Overnight Digest: Stocks to look out on February 26
Overnight Digest: Stocks to look out on February 26

Overnight Digest: Stocks to look out on February 26

Shohini Nath Article rating: 5.0

The stocks that are likely to witness significant movement on the bourses on February 26 are Thomas Cook, Lupin, Lux Industries, JSPL and Zim Laboratories.

Sensex spikes up by 341 points
Sensex spikes up by 341 points

Sensex spikes up by 341 points

Gayathri Udyawar Article rating: 5.0

The Indian markets zoomed up on Monday on the back of global cues. The BSE Sensex and Nifty50 up 341 and 88 points, respectively in the last trading session of the day.

GE TD India to set up high voltage substation in Gujarat
GE TD India to set up high voltage substation in Gujarat

GE TD India to set up high voltage substation in Gujarat

Nidhi Jani Article rating: 4.5

Through this project, GE T&D will help evacuate around 2500 MW of wind power generated in Gujarat. After execution of this project, various wind farm developers will be able to transmit the power generated in the state to the Green Energy Power Transmission Corridor.

KPR Mill ventures into ethanol production
KPR Mill ventures into ethanol production

KPR Mill ventures into ethanol production

Nidhi Jani Article rating: 3.2

The plant will have a capacity of 90 KLPD and the cost for the project is around Rs. 120 crore. The company expects to start production from this plant in the next season. The main purpose of the venture is to increase value addition and reduce the volatility in its sugar business.

Ten stocks close to their 52-weeks high
Ten stocks close to their 52-weeks high

Ten stocks close to their 52-weeks high

Shital Jibhe Article rating: 5.0

The markets on February 25, 2019 opened gap up. BSE Sensex is trading at 36,091.59, up by 220.11 points and the Nifty is trading at 10,849.55, up by 57.90 points. 

Shilpa Medicare gets USFDA approval for cancer injection
Shilpa Medicare gets USFDA approval for cancer injection

Shilpa Medicare gets USFDA approval for cancer injection

Nidhi Jani Article rating: 4.3

Gemcitabine injection is used in the treatment of ovarian cancer, breast cancer, non-small cell lung cancer and pancreatic cancer. As per IQVIA, the market for the injection is approx US$11.7 million.

JBM Group acquires majority holding in German auto firm
JBM Group acquires majority holding in German auto firm

JBM Group acquires majority holding in German auto firm

Nidhi Jani Article rating: 5.0

The said acquisition would enhance synergies for the JBM Group with new products, global customers and new German technologies. This would help JBM Auto expand its footprints in the global market.

Subsidiary of Aurionpro wins orders; stock rises
Subsidiary of Aurionpro wins orders; stock rises

Subsidiary of Aurionpro wins orders; stock rises

Advait Dharmadhikari Article rating: 5.0

Aurionpro Solutions’ subsidiaries in Singapore and Thailand have bagged two prestigious projects each in the banking and fintech space. The order wins pertain to the company’s transaction banking product called iCashpro+.

Realty stocks upbeat on GST rate cut
Realty stocks upbeat on GST rate cut

Realty stocks upbeat on GST rate cut

Gayathri Udyawar Article rating: 5.0

Real estate stocks were buzzing during the morning session on Monday as the GST Council decided on Sunday to cut GST rates applicable on under-construction houses and affordable housing segment.

RSS
First26712672267326742676267826792680Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR